דר איתן פאר מצגת גלולות

  • Published on
    12-Aug-2015

  • View
    2.849

  • Download
    2

Embed Size (px)

Transcript

  • ' "

  • "

    "

  • 15-35 ' -

    ' - :- GNRH CILIA

    "

    "

  • "

    "

  • "

    "

  • - FSH .. 15" - . - (30 ") ( ) ."

    "

  • , 17 , 2E :- - , , - ligand DNA RNA DNA . , , -- messengers NO, , kinase .- NO ."

    "

  • Pathways for Estrogen Carcinogenesis"

    "

  • , , , . ' C.O.M.T . , , ' . - tissue estrogen levels . - ."

    "

  • "

    "

  • "

    "

  • ?"

    "

  • 2030"

    "

  • 30 ' 20 , , . - Pearl Index- -100 , ( 1200 ).Archer 1708 (26,554 ) 20 ' E 1143 30:-PI- 20 0.88PI- 30 1.02- Rosenberg M.J- Contraception- 1999:60:321-329Archer D- Am J Obstet Gynecol- 1999;185- 39-44

    "

    "

  • 30 20- , 6676 (R.R-1.6) - (R.R=1.3). . .Rosenberg M.J- Contraception- 1995;51:283-288Akerlund M Br J Obstet Gynecol- 1993;100:832-838Appel T.B- Contraception -1987;35:523-532Endrikat J- Contraception 1997;55:131-137"

    "

  • - 30 20Meade 50 30 ' E 60% VTE 20 'Young , , Meade T.B Br Med J 1980;280:1157-1161Young R.L Am J Obstet Gynecol 1999;181:59-62"

    "

  • - , 4 . , Rosenberg M J- Contraception , 1995;52:137-141"

    "

  • . , . , , , . , , , .3 , , ."

    "

  • "

    "

  • "

    "

  • - , , ' ( AKR1C4) . ( LEU VAL). 68% . . . ."

    "

  • GESTODENE ( ). 100%, . . .Wilde MI, Balfour JA, Drugs:1995 Aug:50(2) 364-95"

    "

  • "

    "

  • , , . , .Endrikat J-Contraception 199;60:269-274Crook D Am J Obstet Gynecol- 1993;69:1183-1189Rosenberg MJ Contraception 1996;53:85-9

    "

    "

  • -HDL LDL '- !!- HDL LDL"

    "

  • .. , LDL, ., , , NO . . SHBG"

    "

  • "

    "

  • 70-80%- . - 50% . . , . .

    "

    "

  • "

    "

  • HYSTEROSCOPIC VIEW OF ATROPHIC ENDOMETRIAL CAVITYCourtesy of Panay N"

    "

  • WHY BREAKTHROUGH BLEEDING?Dilated surface vessels in a Norplant user with bleeding on minimal pressureHickey M et al. Hum Reprod 1998;13(11):31903196"

    "

  • "

    "

  • "

    "

  • - - 20 '"

    "

  • 8058 . 77 70% - .18% - ( ). , .

    "

    "

  • "

    "

  • Non Contraceptive Benefits of OCMenorrhgia Irregular mensesEndometrial CADysmenorrheaIron Def. AnemiaAcneHirsutism Ovarian CAFunctional Ov. CystsBenign Breast DisPMSOsteoporosisSalpingitisSherifk K Am J Obstet Gynecol- 1999 ;80- s343-348Thorneycroft I.H- Contraception- 1999;60:255-263"

    "

  • 18% > 5 . HRT"

    "

  • ( , ). B12 -

    - B12 , ."

    "

  • . corneal curvature ."

    "

  • VTE - - 10< - X 4 45< VTE BMI 35< "

    "

  • "

    "

  • "

    "

  • "

    "

  • "

    "

  • "

    "

  • "

    "

  • "

    "

  • "

    "

  • LEPTIN , 167-AA, . , , . ( ) Neuropeptide Y . ( ). .

    "

    "

  • .. E . FSH, GNRH LH . , , , , . = !!- - !!"

    "

  • , , , , . .2 , , . ."

    "

  • - PMS/PMDD .:- , -

    , , , - ( ) "

    "

  • PMS/PMDD . / , . , , , ... , , '."

    "

  • "

    ?

    "

    ***********Hysteroscopic view of endometrial cavity of women taking Norplant (levonorgestrel-releasing contraceptive hormone). ****